STOCK TITAN

Fold Holdings ends $250M equity facility Sept. 3

Fold Holdings ends a $250 million equity purchase facility without penalties and schedules a special shareholder meeting for October 22, 2026.

(Neutral)
(Neutral)
Form Type
424B3

Rhea-AI Filing Summary

Fold Holdings, Inc. (FLD) has an effective prospectus supplement covering up to 9,282,287 shares of common stock, updating its existing Form S-1 registration. The supplement incorporates a recent report that on August 27, 2026 the company elected to terminate its Equity Purchase Facility Agreement, under which an investor had committed to purchase up to $250,000,000 of newly issued common stock, with termination effective September 3, 2026 and no prepayment fees or penalties. The facility had been entirely discretionary for the company and there were no outstanding advance notices when it was ended. Fold Holdings states the facility was terminated to provide the option of alternative financing. The same report notes that the Board of Directors has set October 22, 2026 as the date of a special shareholder meeting, with a record date of September 4, 2026.

Positive

  • None.

Negative

  • None.

Filing Explained

The remaining holder mechanic is contingent registration-rights survival for securities the investor may already hold.

This supplement is a registration-stage disclosure for up to 9,282,287 common shares, not evidence that those shares were sold; the related facility remains scheduled to terminate on September 3, 2026.

When that termination takes effect, the company’s registration-rights obligations also end unless the investor then holds Registrable Securities; obligations for those securities survive.

Shares of common stock covered by prospectus supplement 9,282,287 shares Maximum number of common shares referenced in the prospectus supplement
Equity purchase facility commitment $250,000,000 Maximum aggregate purchase amount the investor committed to under the Equity Purchase Facility Agreement
Common stock last reported sales price $0.4622 per share Nasdaq Capital Market closing price on September 1, 2026
Warrant last reported sales price $0.0676 per warrant Nasdaq Capital Market closing price on September 1, 2026
Warrant exercise price $11.50 per share Each whole warrant exercisable for one share of common stock at this price
Special shareholder meeting date October 22, 2026 Date set by the Board of Directors for the special shareholder meeting
Record date for special shareholder meeting September 4, 2026 Shareholders of record on this date may vote at the special meeting
Facility termination effective date September 3, 2026 Date on which the Equity Purchase Facility Agreement termination becomes effective
Equity Purchase Facility Agreement financial
"party to the Equity Purchase Facility Agreement, dated as of June 16, 2025"
Registration Rights Agreement financial
"the Company and the Investor also entered into a Registration Rights Agreement"
A registration rights agreement is a contract that gives investors the option to have their ownership stakes officially registered with the government, making it easier to sell their shares later. This agreement matters because it provides investors with a clearer path to cash out their investments if they choose, offering more liquidity and confidence in their ability to sell their holdings when desired.
Registrable Securities financial
"with respect to such Registrable Securities will survive such termination"
special shareholder meeting financial
"set October 22, 2026 as the date of a special shareholder meeting"
A special shareholder meeting is an unscheduled gathering of a company’s owners called to decide one or a few specific, often urgent, matters that can’t wait for the annual meeting. It matters to investors because the votes taken can change who controls the company, approve major transactions, alter shareholder rights or corporate strategy—similar to an emergency council meeting where a single decision can shift future value and prompt rapid stock price moves.
Nasdaq Capital Market market
"Name of Each Exchange on Which Registered ... Nasdaq Capital Market"
The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.
Offering Type shelf/secondary

FAQ

What does the new prospectus supplement for FLD cover?

The prospectus supplement for Fold Holdings, Inc. (FLD) updates an existing Form S-1 registration and covers up to 9,282,287 shares of common stock. It mainly incorporates recent disclosures from a Form 8-K, including termination of an equity purchase facility and a scheduled special shareholder meeting.

What equity financing arrangement did FLD terminate and when is it effective?

Fold Holdings elected on August 27, 2026 to terminate its Equity Purchase Facility Agreement. The termination becomes effective on September 3, 2026 under the agreement’s terms, and there were no outstanding advance notices requiring issuance of common stock when the notice was delivered.

How large was FLD’s equity purchase facility that has been terminated?

Under the Equity Purchase Facility Agreement, the investor had committed to purchase, subject to conditions, up to $250,000,000 in newly issued shares of Fold Holdings’ common stock. The company had the right, but not the obligation, to draw on this commitment over time by delivering advance notices.

Did Fold Holdings incur any penalties for terminating the equity purchase facility?

No. Fold Holdings states that it did not incur any prepayment fees or penalties as a result of terminating the Equity Purchase Facility Agreement. The company indicates the facility was ended to provide the option of pursuing alternative financing sources.

What happens to FLD’s registration rights obligations after the facility termination?

Upon the facility’s termination becoming effective, the company’s obligations under the Registration Rights Agreement also terminate, except with respect to any Registrable Securities still held by the investor. Obligations related to those remaining securities will survive under the agreement’s terms.

When is Fold Holdings’ upcoming special shareholder meeting and what is the record date?

Fold Holdings’ Board has set October 22, 2026 as the date of a special shareholder meeting. The record date is September 4, 2026, meaning shareholders of record on that date will be entitled to vote on the matters described in the preliminary proxy statement filed August 7, 2026.

At what prices were FLD stock and warrants trading around this filing?

As of September 1, 2026, Fold Holdings’ common stock traded at a last reported sales price of $0.4622 per share, and its warrants traded at $0.0676 per warrant on the Nasdaq Capital Market, where the securities are listed under the symbols FLD and FLDDW, respectively.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

 

Filed pursuant to Rule 424(b)(3)

Registration No. 333-288623

PROSPECTUS SUPPLEMENT NO. 22

(to Prospectus dated August 11, 2025)

Fold Holdings, Inc.

Up to 9,282,287 Shares of Common Stock

 

This prospectus supplement updates, amends and supplements the prospectus dated August 11, 2025 (as supplemented or amended from time to time, the “Prospectus”), which forms a part of our registration statement on Form S-1 (No. 333-288623). Capitalized terms used in this prospectus supplement and not otherwise defined herein have the meanings specified in the Prospectus.

 

This prospectus supplement is being filed to update and supplement the information in the Prospectus with the information contained in our Current Report on Form 8-K filed with the Securities and Exchange Commission on September 2, 2026 (the “Current Report”). Accordingly, we have attached the Current Report to this prospectus supplement.

This prospectus supplement updates and supplements the information in the Prospectus and is not complete without, and may not be delivered or utilized except in combination with, the Prospectus, including any amendments or supplements thereto. This prospectus supplement should be read in conjunction with the Prospectus and if there is any inconsistency between the information in the Prospectus and this prospectus supplement, you should rely on the information in this prospectus supplement.

Our Common Stock and Warrants are listed on the Nasdaq Stock Market LLC under the symbols “FLD” and “FLDDW,” respectively. The last reported sales price of our Common Stock and Warrants on the Nasdaq Stock Market LLC were $0.4622 per share of Common Stock and $0.0676 per Warrant on September 1, 2026.

Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 7 of the Prospectus and other risk factors contained in the documents incorporated by reference therein, to read about factors you should consider before buying our securities.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the Prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

The date of this prospectus supplement is September 4, 2026.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): August 27, 2026

Fold Holdings, Inc.

(Exact name of registrant as specified in its charter)

Delaware

001-41168

86-2170416

(State or other jurisdiction
of incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

- 1 -


 

 

2942 North 24th Street, Suite 115, #42035

Phoenix, Arizona

 

 

85016

(Address of principal executive offices)

(Zip Code)

 

(866) 365-3277

Registrant’s telephone number, including area code

 

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

Trading Symbol(s)

Name of Each Exchange on Which
Registered

Common stock, par value $0.0001 per share

FLD

Nasdaq Capital Market

Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per share

FLDDW

Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

- 2 -


 

 

ITEM 1.02 TERMINATION OF A MATERIAL DEFINITIVE AGREEMENT.

 

On August 27, 2026, Fold Holdings, Inc. (the "Company") delivered written notice to the investor (the "Investor") party to the Equity Purchase Facility Agreement, dated as of June 16, 2025 (the "Facility"), by and between the Company and the Investor, notifying the Investor of the Company's election to terminate the Facility. In accordance with the termination provisions of the Facility, the termination will become effective on September 3, 2026. As of the date of such notice, there were no outstanding Advance Notices (as defined in the Facility) under which the Company was obligated to issue shares of the Company's common stock, par value $0.0001 per share (the "Common Stock"), to the Investor.

 

As previously disclosed in the Company’s Current Report on Form 8-K filed June 17, 2025, pursuant to the Facility, the Investor had committed to purchase, subject to certain conditions and limitations, up to $250,000,000 in newly issued shares of Common Stock (the "Commitment"), which the Company had the right, but not the obligation, to draw upon from time to time in its sole discretion by delivering advance notices to the Investor. The purchase price per share for shares sold to the Investor under the Facility was calculated upon the terms described therein. In connection with entering into the Facility, the Company and the Investor also entered into a Registration Rights Agreement, dated as of June 16, 2025 (the "Registration Rights Agreement"), pursuant to which the Company agreed to file with the Securities and Exchange Commission a registration statement registering the resale by the Investor of the shares of Common Stock issuable under the Facility.

 

The Company terminated the Facility in order to provide the Company with the option of alternative financing. The Company did not incur any prepayment fees or penalties as a result of terminating the Facility. Upon the termination of the Facility becoming effective, the Company's obligations under the Registration Rights Agreement will also terminate in accordance with the terms thereof, except to the extent the Investor then holds any Registrable Securities (as defined in the Registration Rights Agreement), in which case the Company's obligations under the Registration Rights Agreement with respect to such Registrable Securities will survive such termination.

 

The foregoing description of the Facility and the Registration Rights Agreement is qualified in its entirety by reference to the full text of such agreements, copies of which are incorporated herein by reference as Exhibit 10.1 and Exhibit 10.2, respectively.

ITEM 7.01 REGULATION FD DISCLOSURE.

 

The Company hereby announces that its Board of Directors has set October 22, 2026 as the date of a special shareholder meeting concerning the matters previously disclosed in the preliminary proxy statement filed by the Company on August 7, 2026. The record date for such meeting will be September 4, 2026.

 

The information contained in Item 7.01 of this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly provided by specific reference in such a filing.

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

(d) Exhibits.

Exhibit No.

Description

10.1*^

Equity Purchase Facility Agreement, dated as of June 16, 2025, by and between the Company and the Investor (incorporated by reference to Exhibit 10.1 to that Current Report on Form 8-K filed by the Company on June 17, 2025).

10.2*^

 

Registration Rights Agreement, dated as of June 16, 2025, by and between the Company and the Investor (incorporated by reference to Exhibit 10.2 to that Current Report on Form 8-K filed by the Company on June 17, 2025).

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

* Certain schedules, exhibits and similar attachments have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally a copy of such schedules, or any section thereof, to the SEC upon request.

 

^ Certain portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. The registrant agrees to furnish supplementally an unredacted copy of the exhibit to the Securities and Exchange Commission upon its request.

 

- 3 -


 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

FOLD HOLDINGS, INC.

By:

 /s/ Will Reeves

Name:

Will Reeves

Title:

Chief Executive Officer

Dated: September 2, 2026

 

 

- 4 -